Objective
This study explores how patient decision aids (DAs) for antihyperglycemic agents and statins, designed for use during clinical consultations, are em
bedded into practice, examining how patients and clinicians understand and experience DAs in primary care visits.
Methods
We conducted semistructured in-depth interviews with patients (n = 22) and primary care clinicians (n = 19), and videorecorded consultations (n = 44). Two researchers coded all transcripts. Inductive analyses guided by grounded theory led to the identification of themes. Video and interview data were compared and organized by themes.
Results
DAs used during consultations became flexible artifacts, incorporated into existing decision making roles for clinicians (experts, authority figures, persuaders, advisors) and patients (drivers of healthcare, learners, partners). DAs were applied to different decision making steps (deliberation, bargaining, convincing, case assessment), and introduced into an existing knowledge context (participants¡¯ literacy regarding shared decision-making (SDM) and DAs).
Conclusion
DAs¡¯ flexible use during consultations effectively provided space for discussion, even when SDM was not achieved. DAs can be used within any decision-making model.
Practice implications
Clinician training in DA use and SDM practice may be needed to facilitate DA implementation and promote more ideal-type forms of sharing in decision making.
